Beijing Biostar Pharmaceuticals Co., Ltd.
Beijing Biostar Pharmaceuticals Co., Ltd., commonly referred to as Biostar, is a prominent player in the biopharmaceutical industry, headquartered in Beijing, China. Founded in 2000, the company has established itself as a leader in the development and manufacturing of innovative pharmaceutical products, particularly in the fields of oncology and infectious diseases. Biostar's core offerings include a range of high-quality generic drugs and proprietary formulations, distinguished by their efficacy and safety profiles. The company has achieved significant milestones, including various certifications and partnerships that enhance its market position. With a strong focus on research and development, Biostar continues to expand its operational reach across Asia and beyond, solidifying its reputation as a trusted provider in the global healthcare landscape.
DitchCarbon Score
How does Beijing Biostar Pharmaceuticals Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Beijing Biostar Pharmaceuticals Co., Ltd.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Beijing Biostar Pharmaceuticals Co., Ltd.'s reported carbon emissions
Beijing Biostar Pharmaceuticals Co., Ltd., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and climate action. However, without specific emissions data or reduction initiatives, it is challenging to assess Beijing Biostar Pharmaceuticals' position relative to its peers in terms of climate commitments. The absence of emissions reporting may indicate an opportunity for the company to enhance its environmental strategy and align with industry standards for sustainability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Beijing Biostar Pharmaceuticals Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
